EGFR and lung cancer: Homoharringtonine (HHT)–loaded poly(lactic-co-glycolic acid)-SS-PEG (Zhang et al., 2020a) is an epidermal growth factor receptor (EGFR) aptamer-modified PLGA targeted to the EGFR (which shows high expression in lung cancer cells).